Regulation of inositol 1,4,5-trisphosphate receptors by phosphorylation and adenine nucleotides

Current Topics in Membranes

Volumn 66, Issue C, 2010, Pages 273-298

  Betzenhauser, Matthew J ^a   Yule, David I ^b  

^a Columbia University Medical School ^*  (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955102860     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1063-5823(10)66012-7     Document Type: Chapter

References (105)

1. Antl M., von Bruhl M.L., Eiglsperger C., Werner M., Konrad I., Kocher T., et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 2007, 109:552-559.
2. 2+ in pancreatoma AR4-2J cells. The Journal of Endocrinology 2007, 192:659-668.
3. Avruch J. MAP kinase pathways: The first twenty years. Biochimica et Biophysica Acta 2007, 1773:1150-1160.
4. Bai G.R., Yang L.H., Huang X.Y., Sun F.Z. Inositol 1,4,5-trisphosphate receptor type 1 phosphorylation and regulation by extracellular signal-regulated kinase. Biochemical and Biophysical Research Communications 2006, 348:1319-1327.
5. Bare D.J., Kettlun C.S., Liang M., Bers D.M., Mignery G.A. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: Interaction and modulation by calcium/calmodulin-dependent protein kinase II. The Journal of Biological Chemistry 2005, 280:15912-15920.
6. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nature Reviews. Molecular Cell Biology 2000, 1:11-21.
7. Betzenhauser M.J., Fike J.L., Wagner L.E., Yule D.I. Protein kinase A increases type-2 inositol 1,4,5-trisphosphate receptor activity by phosphorylation of serine 937. The Journal of Biological Chemistry 2009, 284:25116-25125.
8. 2+ release by type-2 and type-3 inositol (1,4,5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. The Journal of Biological Chemistry 2008, 283:21579-21587.
9. Betzenhauser M.J., Wagner L.E., Park H.S., Yule D.I. ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs. The Journal of Biological Chemistry 2009, 284:16156-16163.
10. Betzenhauser M.J., Wagner L.E., Won J.H., Yule D.I. Studying isoform-specific inositol 1,4,5-trisphosphate receptor function and regulation. Methods 2008, 46:177-182.
11. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 2005, 38:261-272.
12. Bezprozvanny I., Ehrlich B.E. ATP modulates the function of inositol 1,4,5-trisphosphate-gated channels at two sites. Neuron 1993, 10:1175-1184.
13. Blondel O., Takeda J., Janssen H., Seino S., Bell G.I. Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. The Journal of Biological Chemistry 1993, 268:11356-11363.
14. 2+ channels. The Journal of Biological Chemistry 2001, 276:13509-13512.
15. 2+ signaling in non-excitable cells. Cell Calcium 2003, 34:431-444.
16. Caron A.Z., Chaloux B., Arguin G., Guillemette G. Protein kinase C decreases the apparent affinity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Cell Calcium 2007, 42:323-331.
17. 2+. The Journal of Membrane Biology 2002, 187:51-64.
18. Csordas G., Renken C., Varnai P., Walter L., Weaver D., Buttle K.F., et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. The Journal of Cell Biology 2006, 174:915-921.
19. Cuevas B.D., Abell A.N., Johnson G.L. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007, 26:3159-3171.
20. Cui J., Matkovich S.J., deSouza N., Li S., Rosemblit N., Marks A.R. Regulation of the type 1 inositol 1,4,5-trisphosphate receptor by phosphorylation at tyrosine 353. The Journal of Biological Chemistry 2004, 279:16311-16316.
21. Dai S., Hall D.D., Hell J.W. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiological Reviews 2009, 89:411-452.
22. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
23. 2+ entry through plasma membrane IP3 receptors. Science 2006, 313:229-233.
24. Dellis O., Rossi A.M., Dedos S.G., Taylor C.W. Counting functional inositol 1,4,5-trisphosphate receptors into the plasma membrane. The Journal of Biological Chemistry 2008, 283:751-755.
25. deSouza N., Cui J., Dura M., McDonald T.V., Marks A.R. A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation. The Journal of Cell Biology 2007, 179:923-934.
26. DeSouza N., Reiken S., Ondrias K., Yang Y.M., Matkovich S., Marks A.R. Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex. The Journal of Biological Chemistry 2002, 277:39397-39400.
27. Ehrlich B.E., Watras J. Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature 1988, 336:583-586.
28. Ferris C.D., Cameron A.M., Bredt D.S., Huganir R.L., Snyder S.H. Inositol 1,4,5-trisphosphate receptor is phosphorylated by cyclic AMP-dependent protein kinase at serines 1755 and 1589. Biochemical and Biophysical Research Communications 1991, 175:192-198.
29. Ferris C.D., Huganir R.L., Bredt D.S., Cameron A.M., Snyder S.H. Inositol trisphosphate receptor: Phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:2232-2235.
30. Ferris C.D., Huganir R.L., Snyder S.H. Calcium flux mediated by purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles is allosterically regulated by adenine nucleotides. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:2147-2151.
31. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiological Reviews 2002, 82:893-922.
32. 2+ release channels. Physiological Reviews 2007, 87:593-658.
33. Geiselhoringer A., Werner M., Sigl K., Smital P., Worner R., Acheo L., et al. IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase. The EMBO Journal 2004, 23:4222-4231.
34. Guillemette G., Balla T., Baukal A.J., Catt K.J. Inositol 1,4,5-trisphosphate binds to a specific receptor and releases microsomal calcium in the anterior pituitary gland. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:8195-8199.
35. Harnick D.J., Jayaraman T., Ma Y., Mulieri P., Go L.O., Marks A.R. The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation. The Journal of Biological Chemistry 1995, 270:2833-2840.
36. 2+ store membrane of saponin-treated guinea pig peritoneal macrophages by inositol 1,4,5-trisphosphate. Journal of Biochemistry 1985, 97:1575-1582.
37. Hunter T. Tyrosine phosphorylation: Thirty years and counting. Current Opinion in Cell Biology 2009, 21:140-146.
38. Iino M. Effects of adenine nucleotides on inositol 1,4,5-trisphosphate-induced calcium release in vascular smooth muscle cells. The Journal of General Physiology 1991, 98:681-698.
39. 2+ channel, is a novel substrate of polo-like kinase 1 in eggs. Developmental Biology 2008, 320:402-413.
40. Jayaraman T., Ondrias K., Ondriasova E., Marks A.R. Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 1996, 272:1492-1494.
41. Kaplin A.I., Snyder S.H., Linden D.J. Reduced nicotinamide adenine dinucleotide-selective stimulation of inositol 1,4,5-trisphosphate receptors mediates hypoxic mobilization of calcium. The Journal of Neuroscience 1996, 16:2002-2011.
42. Khan M.T., Wagner L., Yule D.I., Bhanumathy C., Joseph S.K. Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. The Journal of Biological Chemistry 2006, 281:3731-3737.
43. i responses at fertilization: A role for the MAP kinase pathway. Development 2006, 133:4355-4365.
44. i waves. The Journal of Biological Chemistry 1997, 272:15771-15776.
45. i waves. The Journal of Biological Chemistry 1997, 272:15765-15770.
46. Maeda N., Kawasaki T., Nakade S., Yokota N., Taguchi T., Kasai M., et al. Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. The Journal of Biological Chemistry 1991, 266:1109-1116.
47. Maes K., Missiaen L., De Smet P., Vanlingen S., Callewaert G., Parys J.B., et al. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP. Cell Calcium 2000, 27:257-267.
48. Maes K., Missiaen L., Parys J.B., De Smet P., Sienaert I., Waelkens E., et al. Mapping of the ATP-binding sites on inositol 1,4,5-trisphosphate receptor type 1 and type 3 homotetramers by controlled proteolysis and photoaffinity labeling. The Journal of Biological Chemistry 2001, 276:3492-3497.
49. Maes K., Missiaen L., Parys J.B., Sienaert I., Bultynck G., Zizi M., et al. Adenine-nucleotide binding sites on the inositol 1,4,5-trisphosphate receptor bind caffeine, but not adenophostin A or cyclic ADP-ribose. Cell Calcium 1999, 25:143-152.
50. Mak D.O., Foskett J.K. Single-channel inositol 1,4,5-trisphosphate receptor currents revealed by patch clamp of isolated Xenopus oocyte nuclei. The Journal of Biological Chemistry 1994, 269:29375-29378.
51. Mak D.O., Foskett J.K. Single-channel kinetics, inactivation, and spatial distribution of inositol trisphosphate (IP3) receptors in Xenopus oocyte nucleus. The Journal of General Physiology 1997, 109:571-587.
52. 2+ inhibition. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:15821-15825.
53. Mak D.O., McBride S., Foskett J.K. ATP regulation of type 1 inositol 1,4,5-trisphosphate receptor channel gating by allosteric tuning of Ca(2+) activation. The Journal of Biological Chemistry 1999, 274:22231-22237.
54. Mak D.O., McBride S., Foskett J.K. ATP regulation of recombinant type 3 inositol 1,4,5-trisphosphate receptor gating. The Journal of General Physiology 2001, 117:447-456.
55. 2+ activation uniquely distinguishes types 1 and 3 insp3 receptors. The Journal of General Physiology 2001, 117:435-446.
56. Malathi K., Kohyama S., Ho M., Soghoian D., Li X., Silane M., et al. Inositol 1,4,5-trisphosphate receptor (type 1) phosphorylation and modulation by Cdc2. Journal of Cellular Biochemistry 2003, 90:1186-1196.
57. Malathi K., Li X., Krizanova O., Ondrias K., Sperber K., Ablamunits V., et al. Cdc2/cyclin B1 interacts with and modulates inositol 1,4,5-trisphosphate receptor (type 1) functions. Journal of Immunology 2005, 175:6205-6210.
58. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
59. Matter N., Ritz M.F., Freyermuth S., Rogue P., Malviya A.N. Stimulation of nuclear protein kinase C leads to phosphorylation of nuclear inositol 1,4,5-trisphosphate receptor and accelerated calcium release by inositol 1,4,5-trisphosphate from isolated rat liver nuclei. The Journal of Biological Chemistry 1993, 268:732-736.
60. 2+ release in sarcoplasmic reticulum. The Journal of Biological Chemistry 1984, 259:2365-2374.
61. 2+, and adenine nucleotides. Biochemistry 1986, 25:236-244.
62. Mignery G.A., Newton C.L., Archer B.T., Sudhof T.C. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. The Journal of Biological Chemistry 1990, 265:12679-12685.
63. Missiaen L., Parys J.B., Smedt H.D., Sienaert I., Sipma H., Vanlingen S., et al. Effect of adenine nucleotides on myo-inositol-1,4,5-trisphosphate-induced calcium release. The Biochemical Journal 1997, 325(Pt 3):661-666.
64. 2+ signals by differential expression of IP3 receptor subtypes. The EMBO Journal 1999, 18:1303-1308.
65. Morgan D.O. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annual Review of Cell and Developmental Biology 1997, 13:261-291.
66. 2+ flux in reconstituted lipid vesicles. The Journal of Biological Chemistry 1994, 269:6735-6742.
67. Oakes S.A., Scorrano L., Opferman J.T., Bassik M.C., Nishino M., Pozzan T., et al. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:105-110.
68. Ogawa Y., Ebashi S. Ca-releasing action of beta, gamma-methylene adenosine triphosphate on fragmented sarcoplasmic reticulum. Journal of Biochemistry 1976, 80:1149-1157.
69. 2+ release to ATP in pancreatic acinar cells. The Journal of Biological Chemistry 2008, 283:26081-26088.
70. Patel S., Joseph S.K., Thomas A.P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 1999, 25:247-264.
71. Patterson R.L., Boehning D., Snyder S.H. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annual Review of Biochemistry 2004, 73:437-465.
72. 2+ release in AR4-2J cells. Journal of Cellular Biochemistry 2007, 101:609-618.
73. Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunological Reviews 2009, 228:9-22.
74. Schlossmann J., Ammendola A., Ashman K., Zong X., Huber A., Neubauer G., et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 2000, 404:197-201.
75. Smith J.B., Smith L., Higgins B.L. Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells. The Journal of Biological Chemistry 1985, 260:14413-14416.
76. Smith J.S., Coronado R., Meissner G. Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature 1985, 316:446-449.
77. 2+. Cell Calcium 1997, 21:283-290.
78. Soulsby M.D., Alzayady K., Xu Q., Wojcikiewicz R.J. The contribution of serine residues 1588 and 1755 to phosphorylation of the type I inositol 1,4,5-trisphosphate receptor by PKA and PKG. FEBS Letters 2004, 557:181-184.
79. Soulsby M.D., Wojcikiewicz R.J. The type III inositol 1,4,5-trisphosphate receptor is phosphorylated by cAMP-dependent protein kinase at three sites. The Biochemical Journal 2005, 392:493-497.
80. Soulsby M.D., Wojcikiewicz R.J. Calcium mobilization via type III inositol 1,4,5-trisphosphate receptors is not altered by PKA-mediated phosphorylation of serines 916, 934, and 1832. Cell Calcium 2007, 42:261-270.
81. Sudhof T.C., Newton C.L., Archer B.T., Ushkaryov Y.A., Mignery G.A. Structure of a novel InsP3 receptor. The EMBO Journal 1991, 10:3199-3206.
82. Sugawara H., Kurosaki M., Takata M., Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. The EMBO Journal 1997, 16:3078-3088.
83. 2+ release during oocyte maturation. The Journal of Biological Chemistry 2009, 284:20184-20196.
84. Supattapone S., Danoff S.K., Theibert A., Joseph S.K., Steiner J., Snyder S.H. Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:8747-8750.
85. 2+ release and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2427-2432.
86. Tang T.S., Bezprozvanny I. Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons. The Journal of Biological Chemistry 2004, 279:42082-42094.
87. Tang T.S., Tu H., Wang Z., Bezprozvanny I. Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha. The Journal of Neuroscience 2003, 23:403-415.
88. 2+. Nature 2009, 458:655-659.
89. Taylor C.W., Genazzani A.A., Morris S.A. Expression of inositol trisphosphate receptors. Cell Calcium 1999, 26:237-251.
90. Taylor C.W., Putney J.W., Size of the inositol 1,4,5-trisphosphate-sensitive calcium pool in guinea-pig hepatocytes. The Biochemical Journal 1985, 232:435-438.
91. Tu H., Miyakawa T., Wang Z., Glouchankova L., Iino M., Bezprozvanny I. Functional characterization of the type 1 inositol 1,4,5-trisphosphate receptor coupling domain SII(+/-) splice variants and the Opisthotonos mutant form. Biophysical Journal 2002, 82:1995-2004.
92. Tu H., Wang Z., Nosyreva E., De Smedt H., Bezprozvanny I. Functional characterization of mammalian inositol 1,4,5-trisphosphate receptor isoforms. Biophysical Journal 2005, 88:1046-1055.
93. Turjanski A.G., Vaque J.P., Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 2007, 26:3240-3253.
94. Vanderheyden V., Wakai T., Bultynck G., De Smedt H., Parys J.B., Fissore R.A. Regulation of inositol 1,4,5-trisphosphate receptor type 1 function during oocyte maturation by MPM-2 phosphorylation. Cell Calcium 2009, 46:56-64.
95. Vermassen E., Fissore R.A., Nadif Kasri N., Vanderheyden V., Callewaert G., Missiaen L., et al. Regulation of the phosphorylation of the inositol 1,4,5-trisphosphate receptor by protein kinase C. Biochemical and Biophysical Research Communications 2004, 319:888-893.
96. Wagner L.E., Betzenhauser M.J., Yule D.I. ATP binding to a unique site in the type-1S2- inositol 1,4,5-trisphosphate receptor defines susceptibility to phosphorylation by protein kinase A. The Journal of Biological Chemistry 2006, 281:17410-17419.
97. Wagner L.E., Joseph S.K., Yule D.I. Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation. Journal de Physiologie 2008, 586:3577-3596.
98. Wagner L.E., Li W.H., Joseph S.K., Yule D.I. Functional consequences of phosphomimetic mutations at key cAMP-dependent protein kinase phosphorylation sites in the type 1 inositol 1,4,5-trisphosphate receptor. The Journal of Biological Chemistry 2004, 279:46242-46252.
99. Wagner L.E., Li W.H., Yule D.I. Phosphorylation of type-1 inositol 1,4,5-trisphosphate receptors by cyclic nucleotide-dependent protein kinases: A mutational analysis of the functionally important sites in the S2+ and S2- splice variants. The Journal of Biological Chemistry 2003, 278:45811-45817.
100. Walaas S.I., Nairn A.C., Greengard P. PCPP-260, a Purkinje cell-specific cyclic AMP-regulated membrane phosphoprotein of Mr 260, 000. The Journal of Neuroscience 1986, 6:954-961.
101. Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. The EMBO Journal 1982, 1:945-951.
102. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiological Reviews 1999, 79:143-180.
103. Wojcikiewicz R.J. Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. The Journal of Biological Chemistry 1995, 270:11678-11683.
104. Wojcikiewicz R.J., Luo S.G. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. The Journal of Biological Chemistry 1998, 273:5670-5677.
105. Yang L.H., Bai G.R., Huang X.Y., Sun F.Z. ERK binds, phosphorylates InsP3 type 1 receptor and regulates intracellular calcium dynamics in DT40 cells. Biochemical and Biophysical Research Communications 2006, 349:1339-1344.